<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url>
    <loc>https://klow-peptide.com/news/tirzepatide-essai-phase-1-pediatrique/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>fr</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzépatide : résultats publiés au registre pour une étude de phase 1 terminée sur l'obésité chez des enfants de 6 à 11 ans</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/en/news/tirzepatide-phase-1-pediatric-obesity-study-results/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>en</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatide: registry results posted for a completed Phase 1 obesity study in children aged 6 to 11</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/de/news/tirzepatid-phase-1-ergebnisse-bei-kindern/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>de</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatid: Registerergebnisse zu einer abgeschlossenen Phase-1-Studie bei Kindern von 6 bis 11 Jahren mit Adipositas veröffentlicht</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/es/news/tirzepatida-resultados-fase-1-ninos/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>es</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatida: se publican en el registro los resultados de un estudio de fase 1 completado sobre obesidad en niños de 6 a 11 años</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/pt/news/tirzepatida-fase-1-em-obesidade-pediatrica/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>pt</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatida: resultados publicados no registro para um estudo de fase 1 concluído em obesidade em crianças de 6 a 11 anos</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/ar/news/tirzepatide-phase-1-pediatric-obesity-study-results/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>ar</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>تيرزيباتيد: نشر نتائج في السجل لدراسة مكتملة من المرحلة الأولى حول السمنة في أطفال تتراوح أعمارهم بين 6 و11 عامًا</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/it/news/tirzepatide-fase-1-nell-obesita-pediatrica/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>it</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatide: pubblicati nel registro i risultati di uno studio di fase 1 completato sull'obesità in bambini da 6 a 11 anni</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/pl/news/tyrzepatyd-faza-1-otylosci-u-dzieci/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>pl</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tyrzepatyd: w rejestrze opublikowano wyniki zakończonego badania fazy 1 nad otyłością u dzieci w wieku od 6 do 11 lat</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/ko/news/tirzepatide-phase-1-pediatric-obesity-study-results/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>ko</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>티르제파타이드: 비만을 가진 6~11세 소아 대상 1상 연구가 완료되고 결과가 등록부에 게시됐다</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/ja/news/tirzepatide-phase-1-pediatric-obesity-study-results/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>ja</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>チルゼパチド:6歳から11歳の肥満の小児を対象に完了した第1相試験の結果がレジストリに登録</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/zh/news/tirzepatide-phase-1-pediatric-obesity-study-results/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>zh-tw</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>替爾泊肽：6 至 11 歲兒童肥胖第一期試驗完成，登錄結果已公布</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/ru/news/tirzepatide-phase-1-pediatric-obesity-study-results/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>ru</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Тирзепатид: в реестре опубликованы результаты завершённого исследования фазы 1 при ожирении у детей от 6 до 11 лет</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/nl/news/tirzepatide-fase-1-data-bij-kinderobesitas/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>nl</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatide: registerresultaten gepubliceerd voor een afgeronde fase 1-studie naar obesitas bij kinderen van 6 tot 11 jaar</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/cs/news/tirzepatid-vysledky-faze-1-u-detske/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>cs</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatid: v registru byly zveřejněny výsledky dokončené studie fáze 1 zaměřené na obezitu u dětí ve věku 6 až 11 let</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/sv/news/tirzepatid-fas-1-resultat-fetma-hos/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>sv</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatid: registerresultat publicerade för en avslutad fas 1-studie vid fetma hos barn i åldern 6 till 11 år</news:title>
    </news:news>
  </url>
  <url>
    <loc>https://klow-peptide.com/tr/news/tirzepatide-faz-1-cocuk-obezitesi-sonuclari/</loc>
    <news:news>
      <news:publication><news:name>Klow Peptide</news:name><news:language>tr</news:language></news:publication>
      <news:publication_date>2026-11-18T08:14:55.117Z</news:publication_date>
      <news:title>Tirzepatide: 6-11 yaş çocuklarda tamamlanan Faz 1 obezite çalışmasının kayıt sonuçları yayımlandı</news:title>
    </news:news>
  </url>
</urlset>
